Nothing Special   »   [go: up one dir, main page]

HUP0002359A2 - Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide - Google Patents

Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide

Info

Publication number
HUP0002359A2
HUP0002359A2 HU0002359A HUP0002359A HUP0002359A2 HU P0002359 A2 HUP0002359 A2 HU P0002359A2 HU 0002359 A HU0002359 A HU 0002359A HU P0002359 A HUP0002359 A HU P0002359A HU P0002359 A2 HUP0002359 A2 HU P0002359A2
Authority
HU
Hungary
Prior art keywords
polysaccharide
conjugate
group
immunogenic conjugates
hib
Prior art date
Application number
HU0002359A
Other languages
Hungarian (hu)
Inventor
Milan S. Blake
Peter C. Fusco
Iver Heron
Francis Michon
Original Assignee
North American Vaccine, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North American Vaccine, Inc. filed Critical North American Vaccine, Inc.
Publication of HUP0002359A2 publication Critical patent/HUP0002359A2/en
Publication of HUP0002359A3 publication Critical patent/HUP0002359A3/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A substantially pure Haemophilus influenzae type b (Hib) polysaccharide with a refolded meningococcal outer membrane protein (rPorB) conjugate is new. Also claimed are: (a) a method for preparing an Hib polysaccharide-rRorB conjugate; (b) a Hib polysaccharide-rRorB conjugate obtained by the method of (a); (c) a pharmaceutical composition comprising the conjugate; and (d) a method for inducing an immune response to H. influenzae in an animal.
HU0002359A 1997-09-08 1998-07-17 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide HUP0002359A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5779597P 1997-09-08 1997-09-08

Publications (2)

Publication Number Publication Date
HUP0002359A2 true HUP0002359A2 (en) 2000-11-28
HUP0002359A3 HUP0002359A3 (en) 2001-12-28

Family

ID=22012807

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002359A HUP0002359A3 (en) 1997-09-08 1998-07-17 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide

Country Status (1)

Country Link
HU (1) HUP0002359A3 (en)

Also Published As

Publication number Publication date
HUP0002359A3 (en) 2001-12-28

Similar Documents

Publication Publication Date Title
IE840197L (en) Polysaccharide protein conjugate vaccine
BR9811475A (en) Immunogenic conjugates comprising a group b meningococcal porin and an h polysaccharide. influenzae
CA2047681A1 (en) Vaccines for nontypable haemophilus influenzae
CA2223080A1 (en) Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2,5-anhydro-d-mannose terminal structure and conjugate vaccine thereof
WO1990006696A3 (en) Meningococcal class 1 outer-membrane protein vaccine
AU657487B2 (en) Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations
HUP0103100A3 (en) Immunogenic betha-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
AR243934A1 (en) Improved meningococcal polysaccharide conjugate vaccine
JP2001526902A5 (en)
DK506582A (en) LATEX, BIOLOGICAL ACTIVE LATEX CONJUGATES AND PROCEDURES FOR THEIR PREPARATION
CA2142981A1 (en) Vaccines against group c neisseria meningitidis
CA2146145A1 (en) Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom
EP1378245A3 (en) Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis. Their use in a vaccine
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
AU4545799A (en) Beta2 microglobulin fusion proteins and high affinity variants
EA199700419A1 (en) VACCINE COMPOSITION CONTAINING POLYRIBOSILRIBITOLPHOSPHATE AND METHOD FOR ITS PREPARATION
CA2099707A1 (en) Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
AU3313789A (en) Haemophilus influenza type B oxidized polysaccharide-outer membrane protein conjugate vaccine
NZ233861A (en) An antigenic conjugate of hiv major neutralisation determinant covalently linked to purified outer membrane proteosome of neisseria and pharmaceutical compositions
DK0565590T3 (en) Adhesin oligosaccharide conjugate vaccine against Haemophilus influenzae
CA2148563A1 (en) Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain
HUP0002359A2 (en) Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide
UA27754C2 (en) Combination pediatric vaccine, method of simultaneous combined vaccination
EP1131338A4 (en) Method for the production of purified invasin protein and use thereof
EP0378929A3 (en) Membrane proteins and peptides of haemophilus influenzae type b